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Characteristics of the bacterial microbiome
in association with common intestinal
parasites in irritable bowel syndrome
Laura Rindom Krogsgaard1,2, Lee O ‘Brien Andersen3, Thor Bech Johannesen3, Anne Line Engsbro4,
Christen Rune Stensvold3, Henrik Vedel Nielsen3 and Peter Bytzer1,2
Abstract
Objective: A low prevalence of intestinal parasites has been identiﬁed in individuals with irritable bowel syndrome
(IBS), but potential associations with alterations in the bacterial microbiome remain largely unexplored. We aimed to
investigate the relationship between parasites and bacteria in individuals with IBS in order to identify potential trans-
kingdom microbial characteristics.
Design: Stool samples were collected from the Danish background population classiﬁed into IBS (n= 119), unspeciﬁc
gastrointestinal (GI) symptoms (n= 114), and asymptomatic controls (n= 186) based on the Rome III criteria for IBS.
Bacterial (16S) and eukaryotic (18S) ribosomal DNA was sequenced, and 18S data were merged with data from
conventional parasite laboratory tests. The bacterial microbiome was analyzed according to symptom group and
parasite colonization status.
Results: Bacterial richness and diversity were similar for IBS and controls but higher in those with unspeciﬁc GI
symptoms. A higher abundance of Bacteroides and a lower abundance of Faecalibacterium were detected in
individuals with IBS and unspeciﬁc GI symptoms compared with controls. Principal component analyses indicated
differences in bacterial composition related to parasite colonization rather than symptom group. Parasites were
detected at the lowest frequency in the IBS group (39%) and in samples dominated by Bacteroides. Higher bacterial
richness and diversity were found in parasite-positive samples from controls and those with unspeciﬁc GI symptoms
but not in individuals with IBS.
Conclusion: Parasite colonization, rather than bacterial composition, differed between individuals with IBS and
healthy controls. Parasite colonization was associated to a rich and diverse bacterial microbiome; however, this
association was altered in IBS.
Introduction
The intestinal parasites Dientamoeba fragilis and Blas-
tocystis were previously found to colonize individuals with
IBS at a lower frequency compared with asymptomatic
controls1. This ﬁnding indicates that our understanding of
the role of some intestinal parasites in gastrointestinal
(GI) health and disease is limited. Several studies have
reported a difference in the composition of the bacterial
microbiome in relation to IBS2–16, although with incon-
sistent ﬁndings. Organisms from the different kingdoms
of the gut microbiome coexist and interact17, and given
the fact that some intestinal parasites, such as Blastocystis
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and D. fragilis, are common colonizers of the human GI
tract1,18,19, it is relevant to investigate the lower pre-
valence of intestinal parasites in individuals with IBS in
relation to possible differences in the bacterial micro-
biome. Limited investigation in the ﬁeld has focused on
the association between Blastocystis and the bacterial
microbiome in IBS11,20, identifying differences across
some bacterial groups in relation to colonization with
Blastocystis.
The association between parasites, including D. fragilis
and Blastocystis, and the bacterial microbiome in IBS is
still largely unexplored, but could contribute to a
trans-kingdom understanding of the possible role of the
microbiome in IBS.
The aim of this study was to investigate characteristics
of the bacterial microbiome in IBS related to colonization
with intestinal parasites, focusing on D. fragilis and
Blastocystis, by comparing stool microbiome data from
individuals with IBS with asymptomatic controls and with
individuals with GI symptoms not fulﬁlling the criteria for
IBS.
Methods
We conducted an internet-based cohort study of the
Danish background population in 2010, with a follow-up in
2011; described elsewhere1,21. Brieﬂy, the cohort consisted
of 6112 persons (age, 18–50 years [yr]), who completed a
questionnaire based on the Rome III criteria for IBS22.
Respondents were classiﬁed into four symptom groups:
asymptomatic controls, individuals with IBS (fulﬁlling the
Rome III criteria for IBS and reporting no organic GI
diagnosis) subtyped by the Rome III criteria according to
stool type22, individuals with unspeciﬁc GI symptoms
(reporting GI symptoms within the past 3 months not
fulﬁlling the Rome III criteria for IBS), and individuals with
organic GI disease (reporting a GI diagnosis).
The classiﬁcation into symptom groups by the web-
based questionnaire was validated by telephone interviews
conducted by a blinded physician on a sample of the
population as described elsewhere21.
Consecutive respondents were asked to provide stool
samples, until a pre-speciﬁed number was reached (see
the paragraph on Statistics for details). Sampling kits were
sent by postal mail to those agreeing to submit stool
samples. The kit included two test tubes without addi-
tives. Samples were returned by mail, delivered in the
laboratory the following day. Upon receipt, stool samples
were tested for ova and parasites by microscopy, short-
term in vitro culture for Blastocystis23, and a multiplex
quantitative polymerase chain reaction (qPCR) for D.
fragilis, Cryptosporidium spp., Entamoeba histolytica,
Entamoeba dispar, and Giardia intestinalis24–26. Puriﬁed
DNA was ampliﬁed using four primers targeting nuclear
ribosomal genes (16S for prokaryotes and 18S for
eukaryotes). For prokaryotes, a modiﬁed version of the
published universal prokaryotic primers 341F/806R27 was
used, while three in-house primers (G3F1/G3R1, G4F3/
G4R3, and G6F1/G6R1) were used to amplify eukaryotic
DNA (see supplementary material for details). Sequences
were mapped using BION, a k-mer-based mapping soft-
ware described previously28. A unique taxon was deﬁned
by denotation to a speciﬁc evolutionary taxonomic group.
The data on fungi are still undergoing taxonomic vali-
dation and will be presented elsewhere. Parasite sequen-
cing data were merged with data from routine laboratory
tests, including microscopy, culture, and qPCR presented
earlier1 to ensure the broadest possible and most sensitive
approach to parasite detection. Four categories of parasite
colonization status were studied in relation to the com-
position of bacteria: (i) any parasite-positive/-negative, (ii)
D. fragilis-positive/-negative, (iii) Blastocystis-positive/-
negative, and (iv) positive for multiple parasites (>1)/not
positive for multiple parasites (≤1).
Statistics
Sample size was estimated with the aim to detect a
statistical difference at a signiﬁcance level of 5% in the
prevalence of intestinal parasites between individuals with
IBS (expected prevalence, 30%29) and asymptomatic
controls (expected prevalence, 12%30). Seventy-three
persons with IBS and 73 controls were required, and we
aimed to receive samples from 100 individuals in each
group. In 2010, we requested stool samples from 200
individuals with IBS and 300 controls. In 2011, we
requested samples from 200 individuals with unspeciﬁc
GI symptoms.
Differences in the proportion of positive samples
according to the four parasite colonization categories
between the symptom groups were tested by the χ2-test.
BION data were analyzed in R31 with the PhyloSeq32, and
Vegan packages33, using ggplot234 and Plotly35 for gra-
phical presentation.
Data were rareﬁed to 10,000 sequences in order to
enable comparison of data from samples with a large
variation in number of sequence reads. Richness was
deﬁned as a simple count of unique taxa and reported as
the mean (standard deviation [SD]) of observed unique
taxa. Shannon’s diversity index was used as a measure of
diversity, deﬁned by two components, richness and
evenness; the latter is a term referring to how equal the
abundance of unique taxa is. Differences in bacterial
richness and diversity were compared according to
symptom group and according to parasite colonization
status by two-sided t-tests (when comparing two groups)
or one-way ANOVA (when comparing more than two
groups). In order to visualize general differences of the
bacterial microbiome according to symptom group and
parasite colonization status, principal coordinate analyses
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(PCoA), which reﬂects inter-sample dissimilarity, were
carried out based on Bray–Curtis dissimilarity of the
rareﬁed data. Relative abundance data were based on
rareﬁed sequences and refers to the percentage of total
sequences in a sample assigned to a particular taxon. The
relative abundance of the two most common phyla and
genera was compared between symptom groups by a two-
sided t-test, and bar plots were used to display the relative
abundance of the ten most common genera for each
symptom group.
Based on presence/absence of species, we hypothesized
that if any bacterial species should have a signiﬁcant role
in IBS, it should be present at a lower or higher prevalence
in the IBS group. We deﬁned that potential species of
relevance to IBS should be present with a difference in
prevalence of at least 10% between the IBS group and
asymptomatic controls based on the number of samples
collected. Differences in prevalence of the selected species
between the IBS group and asymptomatic controls were
tested for statistical signiﬁcance by the χ2-test.
Species present at a higher or lower prevalence of at least
10% (1) in the group with unspeciﬁc GI symptoms com-
pared with the IBS group and/or the control group and (2)
between positive and negative samples across the four
parasite colonization status categories were also reported.
All authors had access to the study data and reviewed
and approved the ﬁnal manuscript. The study was
approved by the ethics committee in Region Zealand,
Denmark (SJ-144 and SJ-199) and by the Danish Data
Protection Agency. The study was performed according to
the Declaration of Helsinki.
Results
Stool samples were obtained from 124 individuals with
IBS and 204 asymptomatic controls in 2010 and from 118
individuals with unspeciﬁc GI symptoms in 2011. We
performed 16S rRNA and 18S rRNA gene sequencing on
119 samples from individuals with IBS (62% women; mean
age, 37.2 yr [SD: 7.8]), 186 samples from asymptomatic
controls (39% women; mean age, 37.8 yr [SD: 8.1]), and
114 persons with unspeciﬁc GI symptoms (68% women;
mean age, 36.4 yr [SD: 8.0]). For the remaining samples,
stool was not stored for DNA extraction by mistake. IBS
subtypes according to stool pattern were distributed as
follows: Mixed-IBS, 49 (41%); IBS with diarrhea, 38 (32%);
IBS with constipation, 19 (16%); and un-subtyped IBS, 10
(8%) (missing data for three individuals).
Parasite colonization
Of the 419 samples analyzed, 197 (47%) samples were
positive for parasites with 67 (16%) samples being positive
for multiple parasite species. There was no difference in
frequency of colonization with parasites according to sex
or age (data not shown). Parasite colonization status for
all three symptom groups is presented in Table 1. The
prevalence of parasites was highest in asymptomatic
individuals and lowest in the IBS group across all four
parasite colonization categories.
An overview of parasites detected by sequencing and
routine laboratory methods are listed at genus level in
Table S1. The primers used to amplify eukaryotic DNA
appeared to have low sensitivity with regard to detection
of D. fragilis and to some extent for Entamoeba spp.
Bacterial composition
Richness and diversity
BION mapped 38,534,562 sequences to 1536 unique
taxa across all 419 samples. Richness and diversity did not
differ between the IBS and the control group; however,
higher diversity and richness were found in samples from
individuals with unspeciﬁc GI symptoms (Table 2).
Richness and diversity did not differ according to IBS
subtype or time since onset of symptoms (data not
shown). Richness and diversity were signiﬁcantly higher in
samples positive for any parasite, D. fragilis or Blas-
tocystis, and multiple parasite species (Table 2). For
asymptomatic individuals and those with unspeciﬁc GI
symptoms, bacterial richness and diversity was higher in
parasite-positive samples in the four parasite colonization
status categories (Table 3). However, in the IBS group,
Table 1 Prevalence of intestinal parasites in the three symptom groups
Positive for any
parasite, n (%)
Dientamoeba fragilis-
positive, n (%)
Blastocystis-positive, n
(%)
Positive for multiple
parasites species, n (%)
Individuals with IBS, n= 119 46 (39) 29 (24) 21 (18) 12 (10)
Individuals with unspeciﬁc GI
symptoms, n= 114
54 (48) 34 (30) 28 (25) 17 (15)
Asymptomatic controls, n= 186 97 (52) 71 (38) 51 (27) 38 (20)
P value IBS vs asymptomatic 0.02 0.01 0.05 0.02
Difference in prevalence tested by χ2-test
GI gastrointestinal, IBS irritable bowel syndrome
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richness did not differ according to parasite status, and
diversity was only higher in samples positive for Blas-
tocystis or multiple parasites (Table 3).
PCoA
PCoA revealed no separation of samples according to
symptom group, indicating no clear differences in the
bacterial microbiome composition between individuals
with IBS, individuals with unspeciﬁc GI symptoms, and
asymptomatic controls (Figure S1). According to parasite
colonization status, there was no clear separation of
samples; nevertheless, a relative clustering of parasite-
positive samples was apparent, indicating that the pre-
sence of parasites is associated with basic differences in
the bacterial microbiome (Fig. 1).
Relative abundance
The IBS group had a higher abundance of Bacteroidetes
and a lower abundance of Firmicutes compared with
asymptomatic controls (Fig. 2). This was reﬂected in a
higher abundance of Bacteroides and a lower abundance
of Faecalibacterium at genus level in the IBS group
compared with asymptomatic controls (Fig. 2). There was
a similar difference in the dominating phyla and genera
between the group with unspeciﬁc GI symptoms and the
asymptomatic controls, and with even more pronounced
differences between the groups.
The abundance of the ten most common bacterial genera
in combination with parasite colonization status is visualized
in Fig. 3. In general, a low frequency of parasites was found
in samples with a high proportion of Bacteroides. The
samples with a high proportion of Bacteroides had more
than 50% of the bacterial abundance accounted for by the
ten most common genera. Samples not dominated by Bac-
teroides consisted to a greater extent of several different,
low-abundant genera, reﬂecting a more diverse microbiome.
There was no clear clustering of IBS subtype or time
since onset of symptoms in relation to the clustering
based on abundance of genera (Fig. 3).
Prevalence of bacterial species
Based on our deﬁnition of species of particular rele-
vance to IBS, ﬁve species were found at a higher pre-
valence in the IBS group with the difference in prevalence
reaching statistical signiﬁcance for all ﬁve (Table 4). All
ﬁve species, except Blautia faecis, were also found at a
higher prevalence in parasite-negative samples compared
with parasite-positive samples (Table 4).
Five species were found at a higher prevalence in
asymptomatic controls compared with the IBS group,
reaching statistical signiﬁcance for three (Table 4).
For the group with unspeciﬁc GI symptoms, 21 species
were found with a difference in prevalence of at least 10%
compared with the IBS group and/or the asymptomatic
controls (Table S2). In relation to parasite colonization
status, 34 species were found with a difference in pre-
valence of at least 10% between samples positive and
negative for parasites (Table S3).
Discussion
In this study, we investigated the composition of the
bacterial microbiome in IBS in relation to colonization by
Table 2 Bacterial richness and diversity according to symptom group and parasite colonization status
Observed unique taxa
Mean (SD) [P value]
Shannon’s diversity index
Mean (SD) [P value]
Individuals with IBS, n= 119 117.6 (16.6) [0.36]a 3.00 (0.29) [0.59]a
Asymptomatic controls, n= 186 115.8 (16.6) 2.98 (0.32)
Individuals with unspeciﬁc GI symptoms, n= 114 126.0 (21.0) [<0.0001]b 3.07 (0.31) [0.06]b
Positive for any parasite, n= 197 124.2 (17.5) [<0.0001]c 3.09 (0.3) [<0.0001]c
Negative for any parasite, n= 222 114.5 (17.9) 2.94 (0.3)
Dientamoeba fragilis-positive, n= 134 124.0 (17.0) [<0.0001]c 3.08 (0.3) [0.002]c
Dientamoeba fragilis-negative, n= 285 116.7 (18.6) 2.98 (0.3)
Blastocystis-positive, n= 100 126.0 (18.1) [<0.0001]c 3.11 (0.2) [<0.0001]c
Blastocystis-negative, n= 319 116.9 (17.9) 2.98 (0.3)
Positive for multiple parasite species, n= 67 126.3 (16.0) [<0.001]c 3.11 (0.3) [<0.001]c
Negative for multiple parasite species, n= 352 117.7 (18.5) 2.99 (0.3)
GI gastrointestinal, IBS irritable bowel syndrome, SD standard deviation
aDifference between the IBS group and asymptomatic control group tested by two-sided t-test
bDifference between all three symptom groups tested by one-way ANOVA
cDifference between positive and negative samples tested by two-sided t-test
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common intestinal parasites. The bacterial microbiome
displayed marked differences in relation to parasite
colonization status, and we found indications of an altered
relationship between parasites and the bacterial micro-
biome in individuals with IBS.
In general, little difference in the bacterial microbiome
between the IBS group and asymptomatic controls was
observed. A higher abundance of Bacteroides and a lower
abundance of Faecalibacterium were found in individuals
with IBS. However, there was no difference in the overall
composition of the microbiome between IBS and
asymptomatic controls according to richness and diversity
or by PCoA.
On the other hand, clear differences in the structure of
the bacterial microbiome according to parasite coloniza-
tion status were observed in several analyses. PCoA plots
revealed a more distinct dissimilarity between samples in
relation to parasite colonization status than in relation to
symptom group. Individuals colonized with parasites
exhibited a more diverse and rich bacterial microbiome
compared with individuals not colonized by parasites,
which conﬁrms earlier ﬁndings related to Blastocystis36,37.
High bacterial diversity and richness is considered an
attribute of a healthy microbiome38, and a decline in
diversity and richness has been linked to several disease
states39–41. The concept of parasites as inhabitants of a
healthy, diverse microbiome complements associations of
parasites to health-promoting features of the micro-
biome42,43 and the hygiene hypothesis44–46.
Higher richness and diversity in parasite-positive sam-
ples was observed in asymptomatic individuals and in
individuals with unspeciﬁc GI symptoms but could not be
Fig. 1 PCoA of the bacterial microbiome according to parasite colonisation status. Principal coordinate analysis visualizing differences in the
bacterial microbiome between samples positive and negative for any parasite (a), multiple parasites (b), Dientamoeba fragilis (c), and Blastocystis (d). All
samples are included in the analysis (n= 419). Blue dots represent samples positive in the given parasite category while negative samples are
represented by red dots. The closer the dots are ordinated, the more similar the microbiome. Axes summarize the variability in the data, and the value
indicates the variation captured in the axis
Krogsgaard et al. Clinical and Translational Gastroenterology  (2018) 9:161 Page 6 of 11
Ofﬁcial journal of the American College of Gastroenterology
generalized to the IBS group, which suggests that the
relationship between parasites and the bacterial micro-
biome is altered in individuals with IBS compared with
non-IBS individuals.
The overall association between abundance of bacteria
and parasite colonization appeared similar in the three
symptom groups (Fig. 3); samples with a high proportion
of Bacteroides were dominated by this genus to an extent
leading to less diversity, also reﬂected by a very low fre-
quency of colonization with parasites.
The inverse relationship between colonization with D.
fragilis and Blastocystis and a high abundance of Bacter-
oides conﬁrms earlier ﬁndings20,37,47.
Interestingly, even though we did not ﬁnd any major
differences in the composition of the microbiome
between IBS and controls, the bacterial microbiome of
individuals belonging to the group with unspeciﬁc GI
symptoms displayed distinct features.
The symptoms represented by the group with unspeciﬁc
symptoms are very common, as they are reported by
29.5% of the Danish background population48. Most
individuals with unspeciﬁc symptoms fulﬁlled ≥two of
three IBS criteria regarding the association of abdominal
pain to bowel habits as deﬁned by the Rome III criteria,
but symptoms were reported to occur at a lower fre-
quency and of shorter duration (<6 months)48. Our data
suggest that these unspeciﬁc GI symptoms are associated
with a more pronounced alteration in the bacterial
microbiome compared with the chronic condition of IBS.
The group with unspeciﬁc GI symptoms reported a high
yearly incidence of IBS (18.7%)21, and investigating a
possible association between the high incidence of IBS
and the detected aberrations of the bacterial microbiome
in this group, would be of great interest. Interestingly, the
ﬁnding of pronounced changes of the bacterial
microbiome in the group with unspeciﬁc symptoms
rather than in the IBS group does not apply to ﬁndings
related to parasite colonization. Individuals with IBS dis-
played the greatest deviation from the high prevalence of
parasite colonization observed in asymptomatic controls.
Findings of a similar diversity and richness in indivi-
duals with IBS and controls conﬁrms a previous study2,
while most studies found a lower diversity in the IBS
population3–5,7,8,12–14,49,50, and two studies reported a
higher diversity in IBS15,51. The ﬁnding of Bacteroidetes
being more prevalent in IBS is supported by some stu-
dies3,5,15 while others ﬁnd that Bacteroidetes is more
abundant in healthy controls8,11–13.
When comparing the ten species with a difference in
prevalence between IBS and controls (Table 4) with data
from previous studies2–16, we could not ﬁnd support for
any particular clinical relevance to IBS.
The strengths of our study include the fact that stool
samples were collected in the background population and
that we had large sets of samples representing each
symptom group. We compared the structure of the
microbiome in individuals with IBS not only with that of
asymptomatic controls, but also with individuals with
unspeciﬁc GI symptoms, as alterations in the microbiome
should not only enable discrimination between IBS and
asymptomatic individuals, but also between individuals
with IBS and those with GI symptoms not categorized as
IBS, in order to be of clinical relevance. We established
the presence of parasites by both sequencing of the 18s
gene and by routine laboratory tests and a low sensitivity
for D. fragilis and to some extent Entamoeba spp. was
evident by 18S sequencing. This is a relevant ﬁnding with
regard to interpretation of analyses based on sequencing
data as they could underestimate the presence of D. fra-
gilis in samples.
Fig. 2 Mean relative abundance of the two most abundant phyla and genera in the three symptom groups. Error bars indicate 1 s.d. of the mean.
A signiﬁcant difference between symptom groups according to a two-sided t-test is marked with *p < 0.05 or **p < 0.001
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Limitations to the present study include the limited
characterization of the study population. Information on
demographics and characterization of GI symptoms
according to the Rome III criteria were available, but we
had no information on possible diagnoses not related to
the GI tract, medication use and diet, which are all factors
that could inﬂuence the composition of the gut micro-
biome. Stool samples were returned by postal mail in
tubes with no additives, which could affect the composi-
tion of the microbiome compared with immediate freez-
ing at −80 °C52. However, studies have shown that the
effect of interperson variability is larger than effect of
storage methods on bacterial composition53,54.
Numerous studies of the bacterial microbiome in IBS
have not been able to identify distinct reproducible
changes in relation to IBS which questions a possible
signiﬁcant and causal relation. However, many factors
have the potential to affect data on the microbiome; both
factors unrelated to the study setting and factors
embedded in the study design leading to variance in
ﬁndings between studies. Even so, a distinct feature of the
bacterial gut microbiome directly involved in the
Fig. 3 Relative abundance of the ten most abundant bacterial genera found in each of the three symptom groups. Each bar illustrates the
bacterial abundance in one stool sample from an individual. Samples are ordered according to a hierarchical clustering, grouping samples with a similar
bacterial composition. Plot a includes samples from individuals with irritable bowel syndrome (IBS), plot b includes samples from individuals with
unspeciﬁc GI symptoms, and plot c includes samples from asymptomatic controls. The two horizontal bars below plot a show the IBS subtype and time
since onset of symptoms of each sample. Additionally, the four horizontal bars below each of the three plots indicate the presence or absence of *, any
parasite; **, Dientamoeba fragilis; ***, Blastocystis; and ****, multiple parasites. Notable clusters of samples with low prevalence of parasites are
highlighted with a black box
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pathogenesis of IBS should be expected to be evident with
some coherence between studies. Two studies have found
that only a subgroup of IBS patients differ in composition
of the bacterial microbiome compared with healthy con-
trols8,15, which could explain why no distinct changes
were found in the overall comparison of IBS and controls.
Data from this study did not cluster IBS samples into such
subgroups (data not shown).
This study sought to analyze the bacterial microbiome
in the context of parasite colonization status and illu-
strated the importance of integrating the various taxo-
nomic kingdoms when studying the composition of the
microbiome. Observations of parasite colonization being
associated to healthy features of the gut microbiome
should differentiate our view of intestinal parasites
beyond the focus on pathogenicity. Further investigation
into the altered relationship of parasites and the bacterial
microbiome in IBS could contribute to clarifying its
potential for distinguishing IBS from both asymptomatic
individuals and individuals with GI symptoms not ful-
ﬁlling the criteria for IBS.
In conclusion, little difference in bacterial composition
was observed between individuals with IBS and healthy
controls. Parasite colonization was associated to a healthy
state, with parasites colonizing 50% of asymptomatic
controls, while a signiﬁcantly lower colonization rate was
observed in individuals with IBS. The bacterial micro-
biome displayed clear differences related to parasite
colonization status. Presence of parasites was associated
to a rich and diverse microbiome in healthy controls and
individuals with unspeciﬁc GI symptoms; however, this
association was altered in individuals with IBS. The sig-
niﬁcance of this should be investigated further to under-
stand possible trans-kingdom changes of the microbiome
in IBS.
Study Highlights
What is current knowledge?
● Alterations of the bacterial microbiome is reported
in IBS, although with inconsistent ﬁndings.
● Individuals with IBS are less frequently colonized
with intestinal parasites.
What is new here?
● Colonization with parasites is associated with a
high diversity and richness of the bacterial
microbiome in asymptomatic controls and
individuals with non-IBS symptoms.
● This association between parasites and bacteria is
altered in individuals with IBS.
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